Loading clinical trials...
Loading clinical trials...
The purpose of this study is to test whether or not a new contrast agent called Combidex, a contrast agent formulated from ultra-small superparamagnetic iron oxide (USPIO) improves the ability of Magn...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Health Network, Toronto
Collaborators
NCT06919965 · Non-Muscle Invasive Bladder Neoplasms
NCT04389632 · Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck, and more
NCT07495072 · Urinary Bladder Neoplasms, BCG-Induced Cystitis
NCT05316155 · Non-Muscle Invasive Bladder Neoplasms
NCT07222488 · Bladder Cancer, Urinary Bladder Neoplasms
Princess Margaret Hospital
Toronto, Ontario
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions